Damian Eade

Digital

Webinar wrap-up: How pharma can leverage AI-driven synthetic...

Synthetic personas turn static, traditional personas into interactive, evidence-backed simulations.

Digital

Cracking the code: Unlocking key opinion leaders in the digi...

With new guidance, treatment pathways, and medical advances emerging on a regular basis, the pursuit of knowledge and innovation is a never-ending process for healthcare providers.

News

Sanofi abandons phase 3 trial of neurology drug riliprubart

Sanofi's neurology pipeline has had a hole blown in it after a phase 3 trial of riliprubart in rare disease CIDP was stopped for futility.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks